FINAL STLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Stellantis N.V. Investors to Join the Class Action Lawsuit!

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Stellantis N.V. ("Stellantis" or "the Company") (NYSE:STLA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged […]

FINAL SYM DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Symbotic, Inc. Investors to Join the Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Symbotic, Inc. ("SYM" or "the Company") (NASDAQ:SYM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for

FINAL EXTR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Extreme Networks, Inc. Investors to Join the Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Space Development Agency Award Continues Iridium’s Commercial Innovation Delivery Strategy for Government

Iridium Communications Inc. (Nasdaq: IRDM), a leading provider of global voice and data satellite communications, today announced the Space Development Agency (SDA) has awarded the General Dynamics Mission Systems (GDMS) and Iridium team a $491.6 million contract modification in support of its Ground Management and Integration (GMI) program for the Proliferated Warfighter Space Architecture (PWSA).

Gogo Galileo Tour Launches Nationwide

State-of-the-Art Mobile Demo Room Coming to a City Near You Gogo Business Aviation (NASDAQ: GOGO) is launching a nationwide tour bringing its interactive Gogo Galileoexperience to business aviation professionals across the United States. The state-of-the-art mobile demo room was designed to give customers and business aviation professionals from across the industry the ability to experience

FINAL PPD DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds PDD Holdings Inc. f/k/a Pinduoduo Inc. Investors to Join the Class Action Lawsuit!

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PDD Holdings Inc. f/k/a Pinduoduo Inc. ("PDD" or "the Company") (NASDAQ:PDD) and certain of its officers. Class Definition This lawsuit seeks to recover damages

enCore Energy Continues to Encounter High Grade Drill Results from the Alta Mesa Uranium Project

NASDAQ:EU TSXV:EU www.encoreuranium.com enCore Energy Corp. (NASDAQ:EU)(TSXV:EU) (the “Company” or “enCore”), a United States uranium producer, announced today on-going positive results from its Alta Mesa In-Situ Recovery Central Processing Plant (“CPP”) and Wellfield drill program. Drilling, designed to expand the producing wellfield capacity, continues to significantly exceed the cutoff grade thickness requirements for In-Situ Recovery

G Mining Ventures Files NI 43-101 Technical Report for the Oko West Gold Project in Guyana

G Mining Ventures Corp. (“GMIN” or the “Corporation”) (TSX: GMIN) (OTCQX: GMINF) today announced that the Corporation has filed a National Instrument 43-101 Standards of Disclosure for Mineral Projects (“NI 43-101”) Preliminary Economic Assessment (“PEA”) technical report for GMIN’s 100% owned Oko West gold project in Guyana, with an effective date of September 4, 2024

Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals’ EP-104IAR for the Treatment of Knee Osteoarthritis

— Publication ofEupraxia’s Phase 2b data in Lancet Rheumatology, a distinguished and respected journal, raises the profile of EP-104IAR. — As outlined inLancet Rheumatology, Eupraxia’s EP-104IAR imparts clinically significant and durable pain relief, while also having minimal changes in glucose and cortisol, along with stable fluticasone proportionate concentrations in plasma. — The U.S. Centers for

AWH to Hold Third Quarter 2024 Earnings Conference Call on Tuesday November 12, 2024

Ascend Wellness Holdings, Inc. (“AWH” or the “Company”) (CSE: AAWH-U.CN) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, today announced that it will hold a conference call on Tuesday, November 12, 2024, at 8:30 AM ET following the release of its third quarter 2024 financial results. https://mma.prnewswire.com/media/2529835/Ascend_Wellness_Holdings__Inc__AWH_to_Hold_Third_Quarter_2024_Ea.jpg The earnings conference call may be accessed

Scroll to Top